FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I): 
where: X denotes CH2-, -CH2CH2- ; Y denotes -CH2- or O; Y1 denotes -CH2- or O; where at least on of Y and Y1 denote -CH2-; R1 denotes H; R2 and R3 independently denote hydrogen; or one of them denotes H2 and the other denotes a branched or straight C1-6alkyl; where the said C1-6alkyl is possibly substituted with one amino, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C3-6cycloalkyl, phenyl; where any phenyl is possibly substituted with one CN; R4 denotes H; R5 denotes halogen; or its pharmaceutically acceptable salt.
EFFECT: compounds inhibit cholesterol absorption, which enables their use in treating and preventing atherosclerosis.
12 cl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS FOR TREATING HYPERLIPIDEMIC CONDITIONS | 2006 |
|
RU2409572C2 |
| DIPHENYLAZETIDINONE DERIVATIVES HAVING INHIBITORY ACTIVITY TOWARDS CHOLESTEROL ABSORPTION | 2004 |
|
RU2380360C2 |
| NEW PIPERIDINES AS CHEMOKINE (CCR) MODULATORS | 2005 |
|
RU2348616C2 |
| SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
| SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2815814C1 |
| 3-AMINO-1-ARYLPROPYLINDOLES APPLIED AS INHIBITOR MONOAMINE REUPTAKE | 2005 |
|
RU2382031C2 |
| NEW P2X7 RECEPTOR ANTAGONISTS, METHOD OF OBTAINING THEM, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE, BASED ON ANTAGONISTS | 2004 |
|
RU2347778C2 |
| DERIVATIVES OF OXAZOLIDINE ANTIBIOTICS | 2008 |
|
RU2506263C2 |
| ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
| POLYCYCLIC AGENTS FOR TREATING RESPIRATORY SYNCYTIAL VIRAL INFECTIONS | 2004 |
|
RU2422444C2 |
